$14.41
-0.01 (-0.07%)
Performance
1D
—
1W
—
1M
—
3M
+1.12%
6M
+74.88%
1Y
+67.17%
YTD
+0.98%
Open$14.40
Previous Close$14.42
Day High$14.41
Day Low$14.40
52W High$14.38
52W Low$5.51
Volume—
Avg Volume3.87M
Market Cap4.50B
P/E Ratio—
EPS$-0.09
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$13.59
Above
SMA 200
$8.96
Above
RSI (14)
72.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
14 analysts
Price Target
+623.5% upside
Current
$14.41
$14.41
Target
$104.26
$104.26
$68.91
$104.26 avg
$125.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 645.35M | 518.65M | 353.38M |
| Net Income | -27,581,416 | -19,949,589 | 71.26M |
| Profit Margin | -4.3% | -4.1% | 20.2% |
| EBITDA | 51.37M | 39.22M | 123.65M |
| Free Cash Flow | — | — | 60.51M |
| Rev Growth | +24.4% | +24.4% | +12.1% |
| Debt/Equity | 1.43 | 1.43 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |